Pharmaceuticals

Global Opioids Market Expected To Reach $168.99 Billion By 2030 With 9.1% CAGR

May 1, 2026May 6, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

What Is The Projected Increase In Market Value Of The Opioids Market During 2026–2030?

The opioids market size has witnessed steady expansion in recent years. This market is anticipated to expand from $23.98 billion in 2025 to $24.63 billion in 2026, driven by a compound annual growth rate (CAGR) of 2.7%. Historically, this growth can be ascribed to factors like the prevalence of post-surgical pain, a rise in cancer incidence, widespread practices of opioid prescription, the restricted availability of alternative pain therapies, and robust hospital-based opioid usage.

The opioids market size is anticipated to demonstrate consistent growth over the coming years. It is projected to expand to $28.59 billion by 2030, achieving a compound annual growth rate (CAGR) of 3.8%. The increase during this forecast period can be attributed to a growing chronic pain population, the development of safer opioid formulations, an expansion of palliative care services, clearer regulatory guidelines for controlled substances, and a rising demand for effective pain management among aging populations. Significant trends in the forecast period involve the development of precision-guided opioid therapy, the integration of digital prescription monitoring, a shift towards abuse-deterrent formulations, the greater availability of long-acting and extended-release opioids, and an increasing application of opioids in oncology pain management.

Access Your Free Sample Report For In-Depth Market Analysis:

https://www.thebusinessresearchcompany.com/sample.aspx?id=13021&type=smp

What Leading Drivers Are Supporting The Opioids Market Expansion?

The rising incidence of chronic diseases is projected to drive the expansion of the opioids market. These enduring medical conditions, also identified as non-communicable diseases (NCDs), are characterized by their gradual progression and prolonged duration, often persisting for many years or even a lifetime without naturally subsiding. The growing frequency of chronic diseases plays a significant role in the opioids market, as the expanding number of individuals experiencing chronic diseases and associated chronic pain leads to a heightened demand for opioids. While complex and continually developing within medicine, the use of opioids in managing chronic diseases effectively alleviates pain. For example, in June 2024, the National Health Service, a UK-based government department, reported that 3,615,330 individuals registered with a general practitioner (GP) were diagnosed with non-diabetic hyperglycemia or pre-diabetes (defined as elevated blood sugar not high enough for diabetes) in 2023. This marked an 18% increase from 3,065,825 cases in 2022. Consequently, the increasing prevalence of chronic diseases is a primary driver for the growth of the opioids market.

How Is The Opioids Market Categorized Across Its Segment Groups?

The opioids market covered in this report is segmented –

1) By Product Type: Methadone, Codeine, Fentanyl, Oxycodone, Morphine, Hydrocodone, Other Product Types

2) By Receptor Binding: Strong Agonist, Mild To Moderate Agonist

3) By Basis Of Indication: Inflammatory Condition, Musculoskeletal Pain, Neuropathic Pain, Cancer Pain

4) By Distribution Channel: Hospital, Retail Pharmacies, Online Pharmacies

5) By Application: Pain Management, Cough Treatment, Diarrhea Treatment

Subsegments:

1) By Methadone: Methadone Tablets, Methadone Oral Solution

2) By Codeine: Codeine Phosphate Tablets, Codeine Liquid Formulations

3) By Fentanyl: Fentanyl Patch, Fentanyl Injection, Fentanyl Sublingual Tablets

4) By Oxycodone: Oxycodone Tablets, Oxycodone Extended-Release Formulations

5) By Morphine: Morphine Sulfate Tablets, Morphine Injection, Morphine Extended-Release Capsules

6) By Hydrocodone: Hydrocodone/Acetaminophen Tablets, Hydrocodone Liquid Formulations

7) By Other Product Types: Buprenorphine, Tramadol, Other Combination Products

What Trends Are Shaping The Future Of The Opioids Market?

Leading companies in the opioid market are concentrating on developing innovative drug solutions to strengthen their position. The introduction of new medications can address diseases and enhance healthcare along with scientific knowledge. For example, in May 2023, Braeburn Pharmaceuticals Inc., a US-based firm providing treatments for opioid addiction, declared that the US Food and Drug Administration had approved Brixadi (buprenorphine) extended-release injectable for subcutaneous administration (under the skin) for managing moderate to severe opioid use disorder (OUD). This product is the first and only weekly and monthly subcutaneous injection for moderate to severe OUD and the initial buprenorphine injectable to incorporate FluidCrystal Injection Depot Technology. Patients currently on oral buprenorphine-containing medications can be transitioned to equivalent dosages if the prescribed advice is followed.

Which Firms Are Influencing Competition In The Opioids Market?

Major companies operating in the opioids market are Pfizer Inc., Johnson & Johnson Inc., AbbVie Inc., Sanofi S.A, AstraZeneca Plc, Viatris Inc., Teva Pharmaceutical Industries Limited, Sandoz Inc., Sun Pharmaceutical Industries Limited, Aurobindo Pharma Limited, Purdue Pharma L.P., Dr. Reddy’s Laboratories Ltd., Hikma Pharmaceuticals plc, Endo Pharmaceuticals Inc., Amneal Pharmaceuticals Inc., Mallinckrodt Pharmaceuticals plc, Alkermes plc, Lannett Co Inc., Par Pharmaceutical Inc., Mayne Pharma Group Ltd., Cephalon LLC, Insys Therapeutics Inc., Janssen Pharmaceuticals Inc., Rhodes Pharmaceuticals L.P, KVK Tech Inc.

Get The Full Opioids Market Report:

https://www.thebusinessresearchcompany.com/report/opioids-global-market-report

Which Region Is The Largest In The Opioids Market?

North America was the largest region in the opioids market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the opioids market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Opioids Market Report For Competitive Insights:

https://www.thebusinessresearchcompany.com/report/opioids-global-market-report

Browse Through More Reports Similar to the Global Opioids Market 2026, By The Business Research Company

Opioids Market Report 2026

https://www.thebusinessresearchcompany.com/report/opioids-global-market-report

Morphine Drugs Market Report 2026

https://www.thebusinessresearchcompany.com/report/morphine-drugs-global-market-report

Opioid Use Disorder Oud Market Report 2026

https://www.thebusinessresearchcompany.com/report/opioid-use-disorder-oud-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795